PetMed Express Revenue Growth: 11.98%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PETS Revenue Growth Rankings
| Overall | 59th percentile | 1800 of 4424 |
| Sector | 57th percentile | 197 of 464 in Healthcare |
| Industry | 18th percentile | 9 of 11 in Drug Delivery & Accessories |
PETS Revenue Growth Range, Past 5 Years
| Minimum | 9.61% | Mar 2005 |
| Maximum | 359.45% | Dec 2001 |
| Average | 76.19% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these PETS related companies
PETS News
PetMed Express Raises Dividend by 20%, Yield Nears 5%: http://stks.co/29iV $PETS
about 13 days ago by DynamicDividend
about 13 days ago by DynamicDividend
PetMed Express, Inc. (PETS) Raises Quarterly Dividend 20% to $0.15; 5% Yield
Jan 30, 8:01AM Street Insider
Jan 30, 8:01AM Street Insider
PetMed Express D/B/A 1-800-PetMeds Announces a 20% Increase to Its Quarterly Dividend
Jan 30, 8:00AM GlobeNewswire
Jan 30, 8:00AM GlobeNewswire
Weekly. Not good for Bulls here, a close just .08c abv the low for the week. 50d test below SOON $PETS http://chart.ly/qnhnnbf
about 15 days ago by 1nvestor
about 15 days ago by 1nvestor
We'll make great $PETS. We'll make great $PETS! Name band for shout-out. Doggy & kitty pharmacy PetMed Express up 12% as EPS top forecasts.
about 20 days ago by lamonicabuzz
about 20 days ago by lamonicabuzz
Petmed Express, Inc. (PETS) Tops Q3 EPS by 3c, Sales Beat Street's Consensus
Jan 23, 8:04AM Street Insider
Jan 23, 8:04AM Street Insider
PetMed Express D/B/A 1-800-PetMeds Announces Third Quarter Financial Results
Jan 23, 8:00AM GlobeNewswire
Jan 23, 8:00AM GlobeNewswire
bot $AMED at 10.12; bot $INFA at 35.97; bot $PETS at 10.89; bot $SWN at 29.59;
about 26 days ago by txbondman
about 26 days ago by txbondman
PetMed Express d/b/a 1-800-PETMEDS to Announce Its Third Quarter Financial Results on January 23, 2012
Jan 17, 8:00AM GlobeNewswire
Jan 17, 8:00AM GlobeNewswire
$PETS http://stks.co/1W3m Fell off my radar for the IRA hold. Still looks great
about 61 days ago by gtotoy
about 61 days ago by gtotoy
$PETS at interesting value level with no debt and 5+% dividend. http://stks.co/16an
about 91 days ago by wsfms
about 91 days ago by wsfms
30 Efficient, Dividend Paying Companies With Cheap Stock Prices $STRA $PETS $LINC $CATO $TNH many others http://stks.co/ctp
about 121 days ago by MagicDiligence
about 121 days ago by MagicDiligence
News and Links from the Magic Formula Investing universe last week $DELL $MSFT $PETS $DLB http://stks.co/Ruj
about 133 days ago by MagicDiligence
about 133 days ago by MagicDiligence
624 liquid stocks went down 5% or more today. 304 reached 20-day low: $nuva $clf $pets $ms
about 144 days ago by ivanhoff
about 144 days ago by ivanhoff
$PETS excellent management, financially strong, increasing profit margins. Beautiful. http://stks.co/DUZ
about 151 days ago by VuruStocks
about 151 days ago by VuruStocks
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PETS | 12.08 | -0.04 | -0.33% | 245.71M |
| ADBE | 32.21 | -0.44 | -1.35% | 15.81B |
| GG | 45.87 | -0.81 | -1.74% | 37.11B |
| CERN | 69.27 | -0.12 | -0.17% | 11.74B |
| EBIX | 25.49 | -0.39 | -1.51% | 954.09M |
| OSTK | 6.96 | -0.20 | -2.79% | 162.03M |
| GRRF | 2.95 | 0.00 | 0.00% | 67.05M |
| ACPW | 0.93 | -0.06 | -6.06% | 74.62M |
| ASUR | 6.77 | 0.02 | 0.30% | 20.92M |
| EQIX | 128.48 | -2.47 | -1.89% | 6.04B |